XML 16 R6.htm IDEA: XBRL DOCUMENT v3.24.2
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit​
Beginning balance (in shares) at Dec. 31, 2022   177,925,631      
Beginning balance at Dec. 31, 2022 $ 3,043,162 $ 1,780 $ 6,311,644 $ (5,236) $ (3,265,026)
Increase (Decrease) in Stockholders' Equity          
Exercise of common stock options (in shares)   88,228      
Exercise of common stock options, net of shares withheld for taxes 964 $ 1 963    
Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures     (13)    
Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures   1,299,071      
Issuance of common stock to fund the Company's 401(k) match (in shares)   517,215      
Stock-based compensation expense 0 $ 13      
Issuance of common stock to fund the Company's 401(k) match 35,077 $ 5 35,072    
Stock-based compensation expense 49,139   49,139    
Net loss (74,151)       (74,151)
Other comprehensive income (loss) 3,517     3,517  
Ending balance (in shares) at Mar. 31, 2023   179,830,145      
Ending balance at Mar. 31, 2023 3,057,708 $ 1,799 6,396,805 (1,719) (3,339,177)
Beginning balance (in shares) at Dec. 31, 2022   177,925,631      
Beginning balance at Dec. 31, 2022 3,043,162 $ 1,780 6,311,644 (5,236) (3,265,026)
Increase (Decrease) in Stockholders' Equity          
Stock-based compensation expense 110,900        
Net loss (155,177)        
Ending balance (in shares) at Jun. 30, 2023   180,545,663      
Ending balance at Jun. 30, 2023 3,056,622 $ 1,806 6,475,742 (723) (3,420,203)
Beginning balance (in shares) at Mar. 31, 2023   179,830,145      
Beginning balance at Mar. 31, 2023 3,057,708 $ 1,799 6,396,805 (1,719) (3,339,177)
Increase (Decrease) in Stockholders' Equity          
Exercise of common stock options (in shares)   36,728      
Exercise of common stock options, net of shares withheld for taxes 852 $ 1 851    
Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures     (1)    
Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures   134,002      
Stock Issued During Period, Value, Employee Stock Purchase Plan 16,344 $ 5 16,339    
Purchase of employee stock purchase plan shares (in shares)   544,453      
Issuance of common stock to fund the Company's 401(k) match (in shares)   335      
Stock-based compensation expense 0 $ 1      
Issuance of common stock to fund the Company's 401(k) match 23 $ 0 23    
Stock-based compensation expense 61,725   61,725    
Net loss (81,026)       (81,026)
Other comprehensive income (loss) 996     996  
Ending balance (in shares) at Jun. 30, 2023   180,545,663      
Ending balance at Jun. 30, 2023 $ 3,056,622 $ 1,806 6,475,742 (723) (3,420,203)
Beginning balance (in shares) at Dec. 31, 2023 181,364,180 181,364,180      
Beginning balance at Dec. 31, 2023 $ 3,145,305 $ 1,815 6,611,237 1,428 (3,469,175)
Increase (Decrease) in Stockholders' Equity          
Exercise of common stock options (in shares)   71,537      
Exercise of common stock options, net of shares withheld for taxes (1,408) $ 1 (1,409)    
Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures (44) $ 17 (61)    
Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures   1,792,087      
Issuance of common stock to fund the Company's 401(k) match (in shares)   617,384      
Issuance of common stock to fund the Company's 401(k) match 40,550 $ 6 40,544    
Stock-based compensation expense 60,370   60,370    
Net loss (110,228)       (110,228)
Other comprehensive income (loss) (1,927)     (1,927)  
Ending balance (in shares) at Mar. 31, 2024   183,845,188      
Ending balance at Mar. 31, 2024 $ 3,132,618 $ 1,839 6,710,681 (499) (3,579,403)
Beginning balance (in shares) at Dec. 31, 2023 181,364,180 181,364,180      
Beginning balance at Dec. 31, 2023 $ 3,145,305 $ 1,815 6,611,237 1,428 (3,469,175)
Increase (Decrease) in Stockholders' Equity          
Stock-based compensation expense 116,900        
Net loss $ (126,036)        
Ending balance (in shares) at Jun. 30, 2024 184,668,188 184,668,188      
Ending balance at Jun. 30, 2024 $ 3,192,362 $ 1,848 6,786,668 (943) (3,595,211)
Beginning balance (in shares) at Mar. 31, 2024   183,845,188      
Beginning balance at Mar. 31, 2024 3,132,618 $ 1,839 6,710,681 (499) (3,579,403)
Increase (Decrease) in Stockholders' Equity          
Exercise of common stock options (in shares)   8,184      
Exercise of common stock options, net of shares withheld for taxes 43 $ 1 42    
Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures (4) $ 2 (6)    
Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures   210,590      
Stock Issued During Period, Value, Employee Stock Purchase Plan $ 19,402 $ 6 19,396    
Purchase of employee stock purchase plan shares (in shares) 604,226        
Stock-based compensation expense $ 56,555   56,555    
Net loss (15,808)       (15,808)
Other comprehensive income (loss) $ (444)     (444)  
Ending balance (in shares) at Jun. 30, 2024 184,668,188 184,668,188      
Ending balance at Jun. 30, 2024 $ 3,192,362 $ 1,848 $ 6,786,668 $ (943) $ (3,595,211)